Harvard Bioscience, Inc. (HBIO) Stock Overview
NASDAQ · Healthcare · Medical Instruments & Supplies
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About Harvard Bioscience, Inc.
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the Americas, Europe, the Middle East, Africa, Asia, and internationally. The company offers cellular and molecular technology products, such as syringe and…
Source: Yahoo Finance
Sector & Industry
Harvard Bioscience, Inc. operates in the Healthcare sector, within the Medical Instruments & Supplies industry group. It is listed on the NASDAQ exchange.
Harvard Bioscience, Inc. at a Glance
| Company | Harvard Bioscience, Inc. |
| Ticker | HBIO |
| Exchange | NASDAQ |
| Currency | USD |
| Price | $8.02 |
| Market cap | $36.51M |
| P/E ratio (trailing) | — |
| EPS (trailing) | -$2.30 |
| 52-week high | $9.40 |
| 52-week low | $3.80 |
| Dividend yield | — |
| Ex-dividend date | — |
| Beta | 1.53 |
| Return on equity (ROE) | -89.95% |
| Debt-to-equity | 595.93% |
| Average volume | 18,050 |
| Shares outstanding | 4.55M |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Employees | 316 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Frequently Asked Questions
- What is Harvard Bioscience, Inc.'s current P/E ratio?
- Harvard Bioscience, Inc. (HBIO) has a trailing P/E ratio of — as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is Harvard Bioscience, Inc.'s market capitalisation?
- Harvard Bioscience, Inc.'s market cap is $36.51M based on our latest snapshot. See how it ranks by market cap →
- What is HBIO's 52-week range?
- Over the past 52 weeks, HBIO has traded between $3.80 and $9.40. What does the 52-week range mean? →
- How volatile is Harvard Bioscience, Inc. compared to the market?
- Harvard Bioscience, Inc. has a beta of 1.53, meaning it has historically moved more than the broader market. What does beta measure? →
- Does Harvard Bioscience, Inc. pay a dividend?
- Harvard Bioscience, Inc. does not currently pay a dividend according to our latest data.
- What exchange is HBIO listed on?
- HBIO is listed on the NASDAQ. Browse all NASDAQ-listed stocks →
- What sector is Harvard Bioscience, Inc. in?
- Harvard Bioscience, Inc. is classified in the Healthcare sector. Compare with Healthcare peers →
Prefer raw numbers at a glance? Browse our size and reference charts for quick lookups.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.
Check Price →Philip Fisher on what makes a business worth owning for the long term.
Check Price →Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →